Correlation Between HUTCHMED DRC and Senti Biosciences
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and Senti Biosciences, you can compare the effects of market volatilities on HUTCHMED DRC and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and Senti Biosciences.
Diversification Opportunities for HUTCHMED DRC and Senti Biosciences
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between HUTCHMED and Senti is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and Senti Biosciences go up and down completely randomly.
Pair Corralation between HUTCHMED DRC and Senti Biosciences
Considering the 90-day investment horizon HUTCHMED DRC is expected to generate 0.71 times more return on investment than Senti Biosciences. However, HUTCHMED DRC is 1.41 times less risky than Senti Biosciences. It trades about 0.04 of its potential returns per unit of risk. Senti Biosciences is currently generating about -0.04 per unit of risk. If you would invest 1,744 in HUTCHMED DRC on August 31, 2024 and sell it today you would earn a total of 99.00 from holding HUTCHMED DRC or generate 5.68% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 98.44% |
Values | Daily Returns |
HUTCHMED DRC vs. Senti Biosciences
Performance |
Timeline |
HUTCHMED DRC |
Senti Biosciences |
HUTCHMED DRC and Senti Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HUTCHMED DRC and Senti Biosciences
The main advantage of trading using opposite HUTCHMED DRC and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.The idea behind HUTCHMED DRC and Senti Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |